Form 4 for HQL abrdn Life Sciences Investors
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-20 · accession 0001104659-23-102460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-20 | 2023-09-20 | HQL | OMSTEAD DANIEL R | Pres, Dir | P - Purchase | $12.68 | +12.0K | 187.4K | +7% | +$152.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Shares of Beneficial Interest | 2023-09-20 | P | A | 12,000 | $12.68 | 187,422.03 | D | — | — |